A new approach to tumescent anesthesia.

Solutio™ is an investigational catheter being developed to deliver tumescent solution from within the target vein during endovenous thermal ablation.

Endovenous ablation has evolved. Tumescent delivery largely hasn’t.

Thermal ablation is performed from inside the vein. Yet tumescent anesthesia commonly involves repeated ultrasound-guided percutaneous access along the treatment segment.

TARGET VEIN / TREATMENT SEGMENT
REPEATED POSITIONING
EXTERNAL PERCUTANEOUS ACCESS
ILLUSTRATIVE — NOT TO SCALE

What if tumescence could be approached from within the vein?

Solutio is being developed to deliver tumescent solution from within the target vein into the surrounding perivascular space.

Designed for a familiar step.

Explore the intended delivery concept in three stages.

Position.

Solutio is positioned within the target vein alongside the thermal device.

Deliver

Under ultrasound guidance, the integrated needle is directed through the vessel wall. Tumescent solution is delivered into the perivascular space.

 

Advance.

The catheter can be repositioned along the treatment segment.

 

One procedure.
A different approach to access.

CURRENT APPROACH

Percutaneous access

Access through the skin, with repeated positioning along the treatment segment.

 

EXTERNAL ACCESS
SOLUTIO™ / INVESTIGATIONAL

From within the vein

Investigational intravascular approach to delivering tumescence into the perivascular space.

INTRAVASCULAR CONCEPT
ENGINEERED WITH PURPOSE

Small device. Significant design consideration.

Every product detail is considered as part of the intended clinical workflow.

Designed around
the procedure.

Patient experience

Designed to reduce reliance on multiple percutaneous needle punctures.

Procedure delivery

An endovascular approach to delivering tumescence around the treatment vein.

Workflow integration

Designed around established thermal ablation workflows.

From innovation
to clinical evidence.

MedVasc is advancing a clinical program designed to evaluate the use of Solutio for intravascular delivery of tumescent anesthesia.

DEVELOPMENT PATH

Illustrative stages — current status to be confirmed

  1. 01

    Concept

  2. 02

    Preclinical

  3. 03

    Clinical

  4. 04

    Regulatory

Evidence first.
Progress with purpose.

The website will evolve as verified study details, publications and regulatory milestones become available. No clinical outcome claims are presented here.

Innovation can happen in the steps we take for granted.

Solutio originated from a clinical observation: while endovenous treatment had evolved, the approach to delivering tumescence remained largely unchanged. MedVasc was founded to explore a different approach.

Dr. Michael Åkesson
Founder, MedVasc

Built with experience in venous intervention.

Karin Ludwigs, MD

Principal Investigator

Cathrin Johansson

CEO

Michael Åkesson, MD

Founder

Follow our progress.

News and clinical-development updates will be shared as they become available and are approved for publication.

Company milestones
June 8, 2026
Dr. Michael Åkesson awarded Honorary Membership in the Seldinger Society
Read more
Company milestones
June 8, 2026
MedVasc Selected for Innovate Nordics 2026
Read more
Clinical milestones
October 27, 2026
MedVasc and Solutio™ Featured in Venous News
Read more

Interested
in Solutio?

We’re engaging with clinicians, researchers and partners as we advance the development of Solutio.

Start a conversation

I'm not a robot